180 related articles for article (PubMed ID: 7673698)
1. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
Basiri H; Kiura K; DeNardin EG; Nakamura I
J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
[TBL] [Abstract][Full Text] [Related]
2. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
[TBL] [Abstract][Full Text] [Related]
3. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
[TBL] [Abstract][Full Text] [Related]
4. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
Kim S; Yokoyama WM
Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
[TBL] [Abstract][Full Text] [Related]
5. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
Lian RH; Freeman JD; Mager DL; Takei F
J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
[TBL] [Abstract][Full Text] [Related]
6. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
Rembecki RM; Bennett M; Kumar V; Potter TA
J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
[TBL] [Abstract][Full Text] [Related]
7. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
[TBL] [Abstract][Full Text] [Related]
9. Evidence for sulfate modification of H-2Dd on N-linked carbohydrate(s): possible involvement in Ly-49A interaction.
Chang CS; Kane KP
J Immunol; 1998 May; 160(9):4367-74. PubMed ID: 9574541
[TBL] [Abstract][Full Text] [Related]
10. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
[TBL] [Abstract][Full Text] [Related]
12. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
Mason LH
J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
Ballas ZK; Rasmussen W
J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
[TBL] [Abstract][Full Text] [Related]
14. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
Milisauskas VK; Nakamura I
Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
[TBL] [Abstract][Full Text] [Related]
15. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I-dependent cell binding to isolated Ly-49A: evidence for high-avidity interaction.
Chang CS; Shen L; Gong DE; Kane KP
Eur J Immunol; 1996 Dec; 26(12):3219-23. PubMed ID: 8977325
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
[TBL] [Abstract][Full Text] [Related]
18. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues.
Lian RH; Li Y; Kubota S; Mager DL; Takei F
J Immunol; 1999 Jun; 162(12):7271-6. PubMed ID: 10358175
[TBL] [Abstract][Full Text] [Related]
19. Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule.
Roth C; Kourilsky P; Ojcius DM
Eur J Immunol; 1994 Sep; 24(9):2110-4. PubMed ID: 8088332
[TBL] [Abstract][Full Text] [Related]
20. Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.
Manilay JO; Waneck GL; Sykes M
J Immunol; 1999 Sep; 163(5):2628-33. PubMed ID: 10453002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
